METACARE CO., Ltd. (KRX:118000)
1,315.00
+2.00 (0.15%)
Sep 4, 2026, 3:30 PM KST
METACARE CO. Revenue
METACARE CO. had revenue of 8.76B KRW in the quarter ending June 30, 2026, with 52.07% growth. This brings the company's revenue in the last twelve months to 39.95B, up 79.86% year-over-year. In the year 2025, METACARE CO. had annual revenue of 32.82B with 62.42% growth.
Revenue (ttm)
39.95B
Revenue Growth
+79.86%
P/S Ratio
0.73
Revenue / Employee
1.29B
Employees
31
Market Cap
29.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.82B | 12.61B | 62.42% |
| Dec 31, 2024 | 20.21B | 2.95B | 17.10% |
| Dec 31, 2023 | 17.26B | -1.84B | -9.64% |
| Dec 31, 2022 | 19.10B | 484.98M | 2.61% |
| Dec 31, 2021 | 18.61B | 11.99B | 181.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.12T |
| Celltrion | 4.90T |
| Samsung Epis Holdings | 1.51T |
| ALTEOGEN | 254.01B |
| Aprogen Biologics | 86.18B |
| BCWORLD PHARM. | 80.33B |
| LabGenomics | 77.64B |
| Tdspharm | 32.90B |